Cargando…
Physicochemical and functional characterization of MYL-1501D, a proposed biosimilar to insulin glargine
Insulin glargine is a long-acting analogue of human insulin that has been used to manage hyperglycemia in patients with diabetes mellitus (DM) for nearly 20 years. Insulin glargine has a relatively constant concentration-time profile that mimics basal levels of insulin and allows for once-daily admi...
Autores principales: | Goyal, Parag, Pai, Harish Venkatraman, Kodali, Phanichand, Vats, Bhavesh, Vajpai, Navratna, Annegowda, Shankara, Mane, Krishnappa, Mohan, Shamini, Saxena, Shruti, Veerabhadraia, Anil Bangalore, Palande, Milee, Nair, Preethy Sasankan, More, Digvijay Chandrashekar, Karudumpa, Umamaheshwara Rao, Jyothirmai, Kunala, Bhattacharya, Adroha, Almeida, Frida, Khyade, Santosh Gulab, Gouda, Shankara, Ranayhossaini, Daniel J., Moole, Praveen Reddy, Smith, Jeffrey P., Barve, Abhijit, Melarkode, Ramakrishnan, Ullanat, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208551/ https://www.ncbi.nlm.nih.gov/pubmed/34133466 http://dx.doi.org/10.1371/journal.pone.0253168 |
Ejemplares similares
-
MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020) -
Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020) -
Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL‐1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus
por: Heise, Tim, et al.
Publicado: (2019) -
Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study
por: Blevins, Thomas C., et al.
Publicado: (2019) -
Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies
por: Sun, Bin, et al.
Publicado: (2021)